Integrated Wealth Management (Palm Desert)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,500	Closed	-$59K	–	1083
2016 Q3	$59K	Hold	4,500	–	–	0.02%	384
2016 Q2	$63K	Hold	4,500	–	–	0.02%	368
2016 Q1	$68K	Hold	4,500	–	–	0.03%	345
2015 Q4	$85K	Hold	4,500	–	–	0.04%	303
2015 Q3	$86K	Hold	4,500	–	–	0.04%	293
2015 Q2	$116K	Buy	4,500 +500	+13%	+$14.2K	0.05%	261
2015 Q1	$125K	Buy	+4,000	New	+$115K	0.05%	252

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s PRTK Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2016, closing a stake of 4,500 shares — an estimated $59K sold.

Integrated Wealth Management (Palm Desert) first reported a position in PRTK in Q1 2015 and held it in 7 quarters. The position peaked at $125K in Q1 2015. 92 funds tracked by Wall St. Rank hold PRTK as of Q4 2016.

Integrated Wealth Management (Palm Desert) reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Integrated Wealth Management (Palm Desert) sold 4,500 Paratek Pharmaceuticals, Inc. shares in Q4 2016, an estimated $59K.
Integrated Wealth Management (Palm Desert) first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
Integrated Wealth Management (Palm Desert)'s Paratek Pharmaceuticals, Inc. position peaked at $125K in Q1 2015.
92 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.